The GACD first call for proposals in 2011 focused on hypertension research in low- and middle-income countries as well as with indigenous populations in Canada and Australia.
Hypertension is a major contributor to the growing global pandemic of cardiovascular disease and stroke. Poor control rates for hypertension and a lack of strategies to maintain normal blood pressure reflect the challenges of effective and affordable implementation in health care and other systems.
The programme builds on previous research that has examined the efficacy and effectiveness of approaches to prevent and control high blood pressure. This programme seeks to improve the implementation of existing approaches to prevention and control rather than to develop new treatments. Prevention is a critical component of all hypertension control programmes and may involve non-medical approaches targeted at individuals or communities.
The long term goal is for the results of projects supported by this funding opportunity to provide healthcare providers and decision-makers with the scientific evidence to implement effective programs that will:
- reduce the prevalence of cardiovascular disease (heart disease and stroke) developing as a consequence of high blood pressure
- inform implementation and enable scale-up of larger programs (including related policies in health and other sectors) at local, national and regional levels
The specific objectives of the programme are:
- To develop a better understanding of key barriers at local, national and international levels that affect hypertension control and to consider how these implementation challenges can be overcome
- To understand how innovations for hypertension control can be introduced and scaled-up across a range of settings
- To identify what elements of systems most need to be strengthened to prevent hypertension and its consequences (e.g. stroke)
- To improve hypertension control rates while reducing disparities in hypertension control across population sub-groups